Cancer Is No Longer a Death Sentence Thanks to Advances in Technology

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, announced that cancer is no longer a death sentence, attributing this shift to advancements in technology that have improved treatment and care for patients.....Read Full Article>>

He made this statement during the opening ceremony of the 2024 International Cancer Week (ICW) on Tuesday in Abuja. This year’s theme is “Accelerating Nigeria’s Path to Comprehensive Cancer Control: Innovation, Access, and Partnership.”

According to Pate, developments in genomics and precision medicine have increased the likelihood of curing more types of cancer. However, he cautioned that the fight against cancer is far from over, highlighting that it has become the fastest-growing non-communicable disease (NCD) in Nigeria.

“We cannot afford to wait until more people are diagnosed with cancer to take action. We lack the resources, infrastructure, and equipment needed to address this issue effectively,” he stated.

As the nation observes Cancer Week, he emphasized the need to reflect on prevention, screening, treatment, rehabilitation, and research efforts. He reaffirmed the Federal Government’s commitment to transforming cancer care based on sound science and research.

Pate also noted that President Bola Tinubu approved the establishment of six major cancer centers and the procurement of essential equipment to alleviate the burden on patients. “Two of these centers are set to be commissioned by May 2025, with the remaining four to follow. We are also expanding diagnostic centers and rebuilding the oncology workforce across the country,” he added.

He encouraged Nigerians to prioritize preventive measures by getting regular screenings.

The event also included the signing of a Memorandum of Understanding (MoU) between the National Institute for Cancer Research and Treatment (NICRAT) and Roche Products Limited focused on the ‘Nigeria Breast Cancer Ambition.’

Dr. Ladi Hameed, General Manager of Roche, stated that the MoU aims to enhance diagnostic capabilities. “By the end of 2025, we will establish six centers equipped with immunohistochemistry diagnostic tools, enabling tailored treatments for specific cancer types. The era of one-size-fits-all cancer treatments is behind us,” he explained.

Hameed further stressed the importance of cancer prevention through routine screenings for early detection, asserting that “awareness and accurate diagnosis are crucial.”

Prof. Usman Aliyu, Director-General of NICRAT, highlighted that the goal of ICW is to promote the adoption of innovative technologies in cancer care and ensure comprehensive training for health professionals. “This initiative will also advocate for the expansion and modernization of cancer care facilities and support comprehensive programs for cancer survivors,” he concluded.